Home / PDIK1L Knockout Cell Lines

PDIK1L Knockout Cell Lines

Gene: PDIK1L

Official Full Name: PDLIM1 interacting kinase 1 likeprovided by HGNC

Gene Summary: Predicted to enable eukaryotic translation initiation factor 2alpha kinase activity. Predicted to be involved in regulation of translational initiation. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO22509 PDIK1L Knockout cell line (HeLa) Human PDIK1L 1:3~1:6 Negative Online Inquiry
KO22510 PDIK1L Knockout cell line (HCT 116) Human PDIK1L 1:2~1:4 Negative Online Inquiry
KO22511 PDIK1L Knockout cell line (HEK293) Human PDIK1L 1:3~1:6 Negative Online Inquiry
KO22512 PDIK1L Knockout cell line (A549) Human PDIK1L 1:3~1:4 Negative Online Inquiry

Background

PDIK1L Gene Knockout Cell Lines are highly specialized cellular models engineered to facilitate the study of the PDIK1L gene, known to play critical roles in various cellular pathways, including cell proliferation and differentiation. Utilizing advanced CRISPR-Cas9 gene-editing technology, these cell lines have had the PDIK1L gene precisely disrupted, enabling researchers to analyze the biological consequences of gene loss and the downstream effects on related molecular mechanisms.

The key functions of PDIK1L include its regulatory roles in signaling pathways associated with tumorigenesis and developmental processes. By leveraging these knockout cell lines, researchers can investigate the gene's contribution to cellular responses to stress, apoptosis, and tumor biology in real-time. This is particularly relevant in cancer research, where understanding the genetic landscape of tumor cells can provide insights into therapeutic targets and treatment strategies.

The scientific importance of PDIK1L Gene Knockout Cell Lines lies in their application across various research domains, including cancer biology, regenerative medicine, and developmental biology. In clinical settings, the ability to model specific genetic alterations aids in the development of personalized medicine approaches. Moreover, the knockout models can serve as invaluable tools for drug screening and efficacy testing, streamlining the pathway to novel treatment options.

One of the primary advantages of our PDIK1L Gene Knockout Cell Lines over alternative models is the accuracy of the gene editing process. Unlike traditional knockout techniques, such as homologous recombination, CRISPR-Cas9 offers a more reliable and straightforward methodology, ensuring precise gene disruption with minimal off-target effects. Moreover, the cell lines come validated with rigorous quality control measures, ensuring researchers can trust their results.

Investing in PDIK1L Gene Knockout Cell Lines empowers researchers and clinicians with innovative tools essential for advancing their understanding of gene function and disease mechanisms. With a commitment to quality and scientific excellence, our company specializes in offering cutting-edge biological products, underpinned by a rich experience in molecular biology and genetic engineering, ensuring our customers can push the boundaries of scientific discovery effectively.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.